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ABSTRACT We report the genome sequence of a severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2) isolate obtained from a patient with symptoms of
coronavirus disease 2019 (COVID-19) who was infected in Cali, Colombia. The patient
had no recent travel record and did not require hospitalization. The virus genome
was obtained using Oxford Nanopore MinION sequencing.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (family Coronaviridae,genus Betacoronavirus) is spreading in the Americas and causing coronavirus
disease 2019 (COVID-19) (1). Up to 14 May 2020, more than 13,000 cases of SARS-CoV-2
infection had been reported in Colombia, with 1,237 of those in the city of Cali.
Genomic information and, above all, the development of local capacity for rapid
molecular characterization of pathogens are crucial for understanding the genomic
composition of the virus population and responding in a timely way to this and other
emerging pathogens. Portable, next-generation sequencing technologies offer a quick
approach to responding to this challenge. We report the coding-complete genome
sequence of SARS-CoV-2 isolate Cali-01, obtained from a Colombian patient with no
recent record of international travel.
SARS-CoV-2 isolate Cali-01 was obtained from a nasopharyngeal swab from a
45-year-old patient who presented with symptoms of COVID-19, including fever,
cough, and throat congestion (2). The sample was collected in viral transport
medium (VTM) following WHO protocols (3) and submitted to the Virology Labo-
ratory of the Universidad del Valle for molecular diagnostics. Viral RNA was purified
from 200 l of VTM using a QIAamp viral RNA minikit (Qiagen), and quantitative
reverse transcription-PCR was carried out by following the CDC 2019-nCoV protocol
(4). For genome sequencing, the RNA sample (cycle threshold value, 16) was diluted
1:10 for cDNA synthesis using random hexamer primers and was PCR amplified
using a total of 218 primer pairs covering the whole virus genome (ARTIC Network
amplicon sequencing protocol v2, with primers v3) (5). Libraries were prepared from
126 ng of DNA using a genomic DNA by ligation sequencing kit (SQK-LSK109;
Oxford Nanopore Technologies), and sequencing was conducted using a FLO-
MIN106D (R9.5) flow cell. Base calling was performed in real time using MinKNOW
v2.0 (raw reads, 103,428 bases; N50, 408 bp). The assembly was performed in two
steps (using default parameters). First, for quality control and filtering of reads
(fragments of 400 to 700 bp), we used the gupplyplex script of the ARTIC Network
bioinformatics protocol (https://artic.network/ncov-2019/ncov2019-bioinformatics
-sop.html), followed by a reference assembly with minimap2 (6) and Pilon (7), using the
sequence of the Wuhan-Hu-1 isolate (GenBank accession number MN908947.3). The
consensus sequence was quality checked using Qualimap v2.2.1 (8) and covered
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the complete reference genome (29,903 nucleotides; GC content, 40.68%) in a contig
of 102,381 reads, with an average coverage depth of 1,111.
For phylogenetic analysis, a data set with 89 additional genome sequences, repre-
senting different GISAID-proposed clades (Fig. 1), was retrieved from GISAID (https://
www.gisaid.org). The alignment was performed using MAFFT (9), implemented via the
rapid phylodynamic alignment pipeline provided by Augur (github.com/nextstrain/
augur) (10). A maximum likelihood phylogeny was reconstructed using IQTREE 2.0.3
(11) with a GTRG model, which was selected using jModelTest 2 (12). We detected
seven mutations, compared to the reference genome, of which three (C241T, C3037T,
and A23122T) are in a noncoding position. Mutations T265I and P4715L are located in
the orf1ab gene, Q57H in the orf3a gene, and D614G in the S gene; this last change
clusters isolates Cali-01 and Bogota78390 in clade G, while isolate Antioquia79256
remains in clade S (due to the L84S change in the orf8 gene) (Fig. 1). The Cali-01
sequence reported here contributes to the ongoing international effort to track and
understand the SARS-CoV-2 pandemic.
This work obtained institutional review board/ethics committee exemption from the
Facultad de Salud of the Universidad del Valle because it relies on laboratory results
that did not involve experimentation with humans. The required documentation is
available upon request.
Data availability. The genome sequence of SARS-CoV-2 isolate Cali-01 was depos-
ited in GISAID and GenBank under accession numbers EPI_ISL_445219 and MT470219,
FIG 1 Maximum likelihood phylogeny of 89 genome sequences reported for SARS-CoV-2 isolates belonging to the G, S, and V clades, obtained from the GISAID
database (https://www.gisaid.org). Values on the branches indicate bootstrap support. Isolate Cali-01 is shown in red, while other isolates from Colombia
(GISAID accession numbers EPI_ISL_417924 [Antioquia] and EPI_ISL_418262 [Bogotá]) are shown in blue.
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respectively. Raw reads were deposited in the GenBank Sequence Read Archive (SRA)
under accession number SRX8341156 (BioProject number PRJNA632678 and BioSample
number SAMN14917563).
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